Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (37)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tavío, M. d. M.
Right arrow Articles by de Anta, M. T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tavío, M. d. M.
Right arrow Articles by de Anta, M. T. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1999) 44, 735-742
© 1999 The British Society for Antimicrobial Chemotherapy

Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates

María del Mar Tavíoa,*, Jordi Vilab, Joaquím Ruizb, José Ruiza, Antonio Manuel Martín-Sáncheza and María Teresa Jiménez de Antab

a Microbiology, Department of Clinical Sciences, School of Medicine, University of Las Palmas de Gran Canaria, Dr. Pasteur s/n, 35080 Las Palmas; b Department of Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain

Eighteen quinolone-resistant isolates of Escherichia coli were selected by exposing ten clinical isolates to increasing concentrations of norfloxacin and lomefloxacin. The mutant isolates showed a multiple-antibiotic-resistance phenotype. All of them contained single mutations in gyrA consisting of the substitution of Ser-83->Leu (n = 14), Val (n = 1) or Ala (n = 1) and the substitution of Asp-87->Asn (n = 2). Only one concomitant mutation in parC (Ser-80->Arg) was detected. Four parent isolates exhibited a single mutation in gyrA which required <=12 mg/L of norfloxacin to be inhibited. Fluoroquinolone resistance, in the 18 quinolone-resistant mutants, was a result of mutations affecting DNA gyrase plus decreased fluoroquinolone uptake. This latter mechanism of resistance was a combined effect of an absence of OmpF and an increase in active efflux in eight isolates, or an increased active efflux alone in the remaining ten selected mutants.

* Corresponding author. Tel:+34-28-451459; Fax: +34-28-451416; E-mail: mtavio{at}infovia.ulpgc.es


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
A. Cesaro, R. R. D. Bettoni, C. Lascols, A. Merens, C. J. Soussy, and E. Cambau
Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes
J. Antimicrob. Chemother., May 1, 2008; 61(5): 1007 - 1015.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
E. Bore, M. Hebraud, I. Chafsey, C. Chambon, C. Skjaeret, B. Moen, T. Moretro, O. Langsrud, K. Rudi, and S. Langsrud
Adapted tolerance to benzalkonium chloride in Escherichia coli K-12 studied by transcriptome and proteome analyses
Microbiology, April 1, 2007; 153(4): 935 - 946.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
X. Y. Han and R. A. Andrade
Brevundimonas diminuta infections and its resistance to fluoroquinolones
J. Antimicrob. Chemother., June 1, 2005; 55(6): 853 - 859.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
M. M Tavio, J. Vila, M. Perilli, L. T Casanas, L. Macia, G. Amicosante, and M. T Jimenez de Anta
Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains
J. Med. Microbiol., November 1, 2004; 53(11): 1119 - 1122.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Wang, J. H. Tran, G. A. Jacoby, Y. Zhang, F. Wang, and D. C. Hooper
Plasmid-Mediated Quinolone Resistance in Clinical Isolates of Escherichia coli from Shanghai, China
Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2242 - 2248.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. Ruiz
Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection
J. Antimicrob. Chemother., May 1, 2003; 51(5): 1109 - 1117.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
Y. Saenz, M. Zarazaga, L. Brinas, F. Ruiz-Larrea, and C. Torres
Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals
J. Antimicrob. Chemother., April 1, 2003; 51(4): 1001 - 1005.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. P. Horcajada, J. Vila, A. Moreno-Martinez, J. Ruiz, J. A. Martinez, M. Sanchez, E. Soriano, and J. Mensa
Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis
J. Antimicrob. Chemother., January 1, 2002; 49(1): 55 - 59.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. Ruiz, A. Jurado, E. Garcia-Mendez, F. Marco, L. Aguilar, M. T. Jimenez de Anta, and J. Vila
Frequency of selection of fluoroquinolone-resistant mutants of Neisseria gonorrhoeae exposed to gemifloxacin and four other quinolones
J. Antimicrob. Chemother., October 1, 2001; 48(4): 545 - 548.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
O. Ciofu, V. Fussing, N. Bagge, C. Koch, and N. Hoiby
Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, {beta}-lactamase activity and RiboPrinting
J. Antimicrob. Chemother., September 1, 2001; 48(3): 391 - 396.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
S. Roychoudhury, T. L. Twinem, K. M. Makin, E. J. McIntosh, B. Ledoussal, and C. E. Catrenich
Activity of non-fluorinated quinolones (NFQs) against quinolone-resistant Escherichia coli and Streptococcus pneumoniae
J. Antimicrob. Chemother., July 1, 2001; 48(1): 29 - 36.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
H. Oh, N. El Amin, T. Davies, P. C. Appelbaum, and C. Edlund
gyrA Mutations Associated with Quinolone Resistance in Bacteroides fragilis Group Strains
Antimicrob. Agents Chemother., July 1, 2001; 45(7): 1977 - 1981.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
F. M. Barnard and A. Maxwell
Interaction between DNA Gyrase and Quinolones: Effects of Alanine Mutations at GyrA Subunit Residues Ser83 and Asp87
Antimicrob. Agents Chemother., July 1, 2001; 45(7): 1994 - 2000.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
A. S. Jellen-Ritter and W. V. Kern
Enhanced Expression of the Multidrug Efflux Pumps AcrAB and AcrEF Associated with Insertion Element Transposition in Escherichia coli Mutants Selected with a Fluoroquinolone
Antimicrob. Agents Chemother., May 1, 2001; 45(5): 1467 - 1472.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
H. Wang, J. L. Dzink-Fox, M. Chen, and S. B. Levy
Genetic Characterization of Highly Fluoroquinolone-Resistant Clinical Escherichia coli Strains from China: Role of acrR Mutations
Antimicrob. Agents Chemother., May 1, 2001; 45(5): 1515 - 1521.
[Abstract] [Full Text]


Home page
J Antimicrob ChemotherHome page
M. d. M. Tavio, J. Vila, J. Ruiz, G. Amicosante, N. Franceschini, A. M. Martin-Sanchez, and M. T. J. de Anta
In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: analysis of the quinolone resistance acquisition
J. Antimicrob. Chemother., April 1, 2000; 45(4): 521 - 524.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.